- Awards & Recognition
- Representative Matters
- Selected Publications
When it comes to complex capital markets transactions, Sean provides clients with the support they need to navigate corporate laws and achieve their business goals. He delivers concise legal advice at all stages of the capital raising process and is a trusted member of any client team.
As a member of the firm's Capital Markets Group, Sean works with private and public companies across a variety of industries, including mining, technology, health and life sciences. His practice focuses on securities law, corporate finance and mergers and acquisitions. Sean frequently advises clients on private placement financings, public offerings, continuous disclosure, reverse takeovers, initial public offerings and stock exchange listings.
Sean joined Aird & Berlis as an associate after summering and articling with the firm.
Awards & Recognition
- Recognized in the Global Top 200 Psychedelics Lawyers Directory 2022 and 2023
Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the launch of its US$35-million at-the-market equity program.
Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of its US$8.25-million overnight marketed public offering of units.
Represented Cybin Inc., a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of a US$30-million common share purchase agreement.
Advised Terminus Capital Partners, an Atlanta-based private equity firm, in its acquisition of actionable insights software platform, Voxco.
Represented: SPARQ Systems Inc., a solar energy solutions company, and MJ Innovation Capital Corp. (TSXV:MSMJ.P), a capital pool company, in connection with SPARQ’s reverse takeover and qualifying transaction on the TSX Venture Exchange and concurrent financing of $10 million. The resulting issuer started trading on January 7, 2022, under the name of SPARQ Corp. and the symbol TSXV:SPRQ.
Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of an overnight marketed offering pursuant to a prospectus supplement to Cybin's short form base shelf prospectus, with aggregate gross proceeds of approximately $34 million.
Represented Spectra7 Microsystems Inc. (TSXV:SEV), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, in the completion of a brokered private placement for aggregate gross proceeds of $14.8 million.
Represented Spectra7 Microsystems Inc. in the completion of brokered and non-brokered private placements.
Represented Galane Gold Ltd. (TSX-V: GG; OTCQB: GGGOF), a gold producer and explorer with mining operations and exploration tenements in Botswana, South Africa and New Mexico, in connection with its acquisition of the Summit Mine and Banner Mill in New Mexico and a million private placement.
Represented Small Pharma Ltd, a U.K.-based neuropharmaceutical company specialized in IP-led development of novel treatments for mental health conditions, in its acquisition by Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) by way of a qualifying transaction and its related brokered and non-brokered private placements for aggregate gross proceeds of $63 million and initial TSX Venture Exchange listing.
Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of a bought deal short form prospectus offering of units for aggregate gross proceeds of approximately $34 million.
Represented Cybin Inc. (the “Company”) (NEO: CYBN) in the completion of its reverse takeover of Clarmin Explorations Inc. pursuant to the terms of an amalgamation agreement among Cybin Corp., Clarmin and a wholly-owned subsidiary of the Company as well as a private placement offering of 60 million subscription receipts for aggregate gross proceeds of $45 million.
Represented Harborside Inc. (formerly Lineage Grow Company Ltd.) (CSE: HBOR) in the completion of its reverse takeover of FLRish, Inc. pursuant to the terms of a merger agreement among the Company, FLRish and Lineage Merger Sub Inc. by way of a “three-cornered merger.”
Represented Eve & Co Incorporated (TSXV: EVE) in the completion of a $10.45 million special warrant bought deal private placement.
Represented Eve & Co Incorporated (TSXV: EVE) in the completion of an $18.7 million construction facility with Royal Bank of Canada to fund the completion of a 780,000 sq. ft. expansion of its greenhouse production facility.
“Historic NFT Insider Trading Charges in U.S. of Relevance to Canadian Operators,” co-authored with Russell J. Sanders and Ali Kwinter, Canadian Securities Law News, no. 343, August 2022.
"TSXV Revises Rules for Security Based Compensation: Implications for the 2022 Proxy Season and Beyond," co-authored with Melanie Cole and Angela Oh, Capital Markets Bulletin, February 2022.
"Disclosure of Non-GAAP Financial Measures: A Practical Guide to National Instrument 52-112," co-authored with Melanie Cole and Al Turnbull, Aird & Berlis LLP Capital Markets Bulletin, January 2022.
"CRA's Super-Priority Remains Operative Over Pre-Bankruptcy Payments to Secured Creditor," co-authored with Alyssa Gebert, Aird & Berlis LLP Financial Services Flash, November 2017.
"NEB Predicts Canadian Fossil Fuel Use Will Peak in 2019," co-authored with David Stevens, Aird & Berlis LLP Energy Insider, November 2017.
"Practically Perfect – Errors in Financing Statements," co-authored with Timothy Jones, Aird & Berlis LLP Financial Services Flash, September 2017.
- JD, Osgoode Hall Law School, 2017
- MA, University of Ottawa, 2015
- BA, University of Ottawa, 2012